Matt TurnerPatient Affordability
Suma Ramadas, PhDMedical Affairs
Joey CohenMedication Adherence
Brenda SnowAuthentic Patient Voice
Paul TheisenPatient Acquisition
Matthew DurhamOmnidynamic Marketing
Daniel SontupeMarket Access
Stacey GandlerBrand Nourishment
Liz KaneImpactful Strategy
Amy GilesIncreasing Engagement
Pat PurcellMeeting Engagement
Bud BilanichSuccess Coach
David LinetskyPoint-of-Care Marketing
Frank BurrellScientific Storytelling
FDA approves Cablivi® (caplacizumab-yhdp), the first Nanobody®-based medicine, for adults with acquired thrombotic thrombocytopenic ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email